ReviewPharmaceutical research2022

Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review.

Manoj K Mahapatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.